Biofrontera Inc. Warrants

Company Profile

Biofrontera Inc. Warrants had its IPO on 2021-10-29 under the ticker symbol BFRIW.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Biofrontera Inc. Warrants has a staff strength of 56 employees.

Stock update

Shares of Biofrontera Inc. Warrants opened at $0.07 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.06 - $0.07, and closed at $0.07.

This is a -10% slip from the previous day's closing price.

A total volume of 1,058 shares were traded at the close of the day’s session.

In the last one week, shares of Biofrontera Inc. Warrants have increased by +68.33%.

Biofrontera Inc. Warrants's Key Ratios

Biofrontera Inc. Warrants has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Biofrontera Inc. Warrants’s revenue was $22.42 million with a gross profit of $0 and an EBITDA of $-7273000. The EBITDA ratio measures Biofrontera Inc. Warrants's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biofrontera Inc. Warrants’s operating margin was -34.91% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, Biofrontera Inc. Warrants’s quarterly earnings growth was a positive 0% while revenue growth was a positive 143.8%.

Biofrontera Inc. Warrants’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.296 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biofrontera Inc. Warrants’s profitability.

Biofrontera Inc. Warrants stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Biofrontera Inc. Warrants stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$41.97 million

Total Liabilities

$20.45 million

Operating Cash Flow

$0

Capital Expenditure

$14000

Dividend Payout Ratio

0%

Biofrontera Inc. Warrants ended 2024 with $41.97 million in total assets and $0 in total liabilities. Its intangible assets were valued at $41.97 million while shareholder equity stood at $16.75 million.

Biofrontera Inc. Warrants ended 2024 with $0 in deferred long-term liabilities, $20.45 million in other current liabilities, 27000.00 in common stock, $-86997000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $13.51 million and cash and short-term investments were $21.10 million. The company’s total short-term debt was $484,000 while long-term debt stood at $0.

Biofrontera Inc. Warrants’s total current assets stands at $37.22 million while long-term investments were $0 and short-term investments were $7.60 million. Its net receivables were $7.87 million compared to accounts payable of $1.80 million and inventory worth $6.67 million.

In 2024, Biofrontera Inc. Warrants's operating cash flow was $0 while its capital expenditure stood at $14000.

Comparatively, Biofrontera Inc. Warrants paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.07

52-Week High

$1.07

52-Week Low

$0.0778

Analyst Target Price

$

Biofrontera Inc. Warrants stock is currently trading at $0.07 per share. It touched a 52-week high of $1.07 and a 52-week low of $1.07. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.1 and 200-day moving average was $0.28 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.